Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
3
×
biotech
boston
boston blog main
fda
san francisco blog main
akouos
andrew berens
aspire capital fund
astellas pharmaceuticals
auris health
avapritinib
blueprint medicines
california institute for biomedical research
cancer
david mcnally
deals
decibel therapeutics
deciphera pharmaceuticals
frequency therapeutics
gastrointestinal stromal tumor
gist
gleevec
harvard university
hearing loss
imatinib
intuitive surgical
investing
jeffrey karp
johnson & johnson
medical device
multiple sclerosis
national
national top stories
perceptive life sciences
raleigh-durham blog main
raleigh-durham top stories
regenerative medicine
What
fda
3
×
plans
3
×
drug
affects
americans
announced
approval
approved
blueprint
cancer
cash
chasing
clearance
company
crunch
date
deadly
deciphera
developing
didn’t
end
filing
forms
frequency
gi
goal
hearing
ipo
loss
medical
medical’s
medicine
medicines
meds
meet
millions
morning
needs
pharamceuticals
regenerative
Language
unset
Current search:
plans
×
fda
×
" national blog main "
×
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug